Autor: |
Tiurin VP, Mezenova TV, Iutrina TO, Usacheva IuV |
Jazyk: |
ruština |
Zdroj: |
Klinicheskaia meditsina [Klin Med (Mosk)] 2013; Vol. 91 (7), pp. 55-60. |
Abstrakt: |
We compared the efficacy of recombinant infliximab and adalimumab in patients with severe and moderately severe rheumatoid arthritis. Infliximab produced rapid anti-inflammatory effect in the early period of therapy whereas adalimumab ensured more stable reduction of clinical and laboratory parameters of activity. |
Databáze: |
MEDLINE |
Externí odkaz: |
|